10 Stocks Under $5 Outperforming in 2012
3. BioDelivery Sciences International (BDSI)
Company Profile: BioDelivery Sciences is a specialty pharmaceutical company focused on pain management and oncology supportive care.
Shares of BioDelivery surged on Jan. 6 after the company struck a licensing and development deal with Endo Pharmaceuticals (ENDP). Endo said it will pay up to $180 million, plus royalties, to BioDelivery Sciences one of the company's pain treatments. Share Price: $2.08 (Jan. 27) 2012 Total Return: 158% Analyst Ratings: Following the announcement of the deal with Endo, Roth Capital, Ladenburg Thalmann and William Blair each came out reiterating "buy" ratings on the stock. The average of the three research firms' price target is $4.67, more than double where the stock currently trades. TheStreet Ratings has a "sell" rating on BioDelivery Sciences.2. EntreMed (ENMD) Company Profile: EntreMed is a pharmaceutical company that is looking to develop and commercialize drugs for the treatment of cancer and inflammatory diseases. Shares of EntreMed rose last Monday after the company announced it secured $10 million in financing. Later in the week, EntreMed rallied sharply after stakeholder Celgene (CELG) announced it would acquire cancer drug maker Avila Therapeutics, which also develops kinase inhibitors. Share Price: $2.60 (Jan. 27) 2012 Total Return: 173% Analyst Ratings: No Wall Street firm currently has coverage of EntreMed. TheStreet Ratings has a "sell" rating on EntreMed.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
